ARCHIVES

In Brief: Doug Ulman named CEO of Pelotonia

This article is from The Cancer Letter archive.

Vol. 40 No. 36 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

March 20, 2009

NCI Cooperative Group Clinical Trials Approved

August 28, 2009

ACS-Led National Cancer Dialogue Beset By Patient Mistrust, Lack Of Openness

January 21, 2000

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

DCPC Suggest Options For Encouraging New Minority Centers

May 4, 1984